PathAI’s Post

[#Lunit #Oncology] Tomorrow afternoon at Translational Digital Pathology & AI Summit, our medical director Dr. Yoojoo Lim will speak about AI-powered digital pathology in drug development. 📆 Wednesday, April 17, 2pm "Analyzing Pathology via AI Models to Augment Drug Development" You can also meet with our team onsite and learn how Lunit SCOPE can help achieve your goals. Ben Goodwin Deboleena Sarkar, Ph.D. Michael Hreczuck #translational #AI #digitalpathology #drugdevelopment #pathologyai #event

Digital pathology revolutionizes cancer diagnosis, making the process more efficient and collaborative. Through AI-based tools, clinical decision support is enhanced, productivity is boosted, and turnaround times in pathology labs are accelerated. Roche Digital Pathology and Ibex have joined forces to further this advancement. Michael Rivers, Lifecycle Leader for Roche Digital Pathology, sheds light on the importance of this partnership. He mentions, "With the Navify Digital Pathology platform, pathologists can securely tap into third-party AI-powered technology along with Roche's AI-based image analysis tools, simplifying clinical workflows." Ibex's AI algorithms are pivotal in this collaboration, aiding clinicians in the precise and efficient diagnosis of breast and prostate biopsies. Beyond supporting accurate cancer diagnosis, these algorithms assist in case prioritization and grading, promoting thorough patient care. This innovative approach is already making a positive impact in labs and hospitals globally. Joseph Mossel, CEO and co-founder of Ibex Medical Analytics talks about the future, stating, "The evolution of digital pathology is headed towards open platforms where technology providers can collaborate to deliver integrated software solutions, ultimately enhancing patient care quality." This collaborative effort, underpinned by the robust infrastructure of Amazon Web Services, exemplifies the synergy between technology and healthcare in improving patient outcomes. #FutureOfHealthcare #Healthcare #CancerDiagnosis #DigitalPathology #HealthTech For more details, check out the full article: https://lnkd.in/gnXt7JXa

Learn tips to achieve "digital ready" slides during this webinar Optimizing your digital pathology upstream workflow will pay dividends once the slide reaches your whole slide scanner #digitalpathology #digitalpathologyupdate

Are you wondering how to mitigate delays in your clinical or research digital pathology workflow? Automating the quality control of histological slides could be the solution. Typically, ensuring whole slide images are free of artifacts before pathology examination demands a substantial human effort, adding between one and five minutes per slide. AiosynQC addresses the burden of this manual process, which is expected to intensify with the rise in cancer cases and the decreasing number of industry professionals. Our advanced artifact detection algorithm enables labs to reduce the time spent on quality checks. AiosynQC is a robust, adaptable solution that seamlessly integrates into your workflow. It supports multiple file formats and offers tailored sensitivity and customizable reporting options to meet your lab’s unique requirements. Ready to streamline your digital pathology workflow? Schedule a demo to experience the solution firsthand and explore our pilot opportunities: https://lnkd.in/eQPGHARF #AIInnovation #AIInPathology #DigitalPathology #PathologyLabs

📢Exciting news! Our exclusive interview with PathAI's leadership, Ben Glass and Saumya Pant sheds light on how they are revolutionizing clinical trials through AI-driven pathology. 🧬💻 PathAI's approach promises to accelerate the development of therapies with improved patient outcomes by enhancing both accuracy and efficiency in clinical trials. Their collaboration with biopharma and research institutions is crucial, with a focus on oncology, metabolic diseases, and more. Digital pathology integration is transforming clinical trial workflows, promoting more targeted patient enrollment. PathAI addresses key challenges including data integrity, patient privacy, and regulatory compliance. Explore the full interview for deeper insights into how PathAI is shaping the future of clinical trials through innovation and collaboration. 🔍 #ClinicalTrials #AI #Pathology #DigitalPathology #Innovation #Biopharma Tafadzwa Muguwe, MD Nick Brown

ESMO - European Society for Medical Oncology Perspectives… Synoptic reporting is an important step of the digital transformation of #pathology. Synoptic reporting not only ensures that all reports contain the necessary data elements but also supports scalable data capture, interoperability, and exchange. Significant progress has been made in recent years in defining the features of synoptic reporting that are most important for effectively generating, reading and digesting, and creating structured data sets from synoptic reports for interoperability and data exchange. The convergence of technology, structured data, and artificial intelligence paves the way for the next generation of synoptic reporting platforms and accelerates the adoption of computational pathology. 🖋️ Catarina Eloy, Paul Seegers, Ekaterina Bazyleva, Filippo Fraggetta

[#Lunit #Oncology] If you are attending the Translational Digital Pathology & AI Summit next week, do not miss the chance to learn more about #AI in #DigitalPathology! Mark your calendar for Wednesday, April 17, 2pm for our presentation: "Analyzing Pathology via AI Models to Augment Drug Development" You can also meet with our team onsite and learn how AI can help achieve your goals. Ben Goodwin Deboleena Sarkar, Ph.D. Michael Hreczuck Click on the link to register and learn more about the event 🔗 https://lnkd.in/gRgdWhAb #translational #digitalpathology #drugdevelopment #pathologyai #event

Download the 1st & only KLAS Research report for Pathology #AI to see customer’s feedback on Ibex Medical Analytics as a key value driver for diagnostic workflows https://lnkd.in/eW9aJ9Mk

🔍 Fascinating insights from Donal O'Shea on Pathology News, a pioneer in #DigitalPathology, highlighting the transformative power of AI in pathology. His journey from academia to founding Deciphex and Diagnexia showcases the evolution of pathology tech and its future potential. 🚀 #Innovation #PathologyNews

Dive into the future with Deciphex! CEO Donal O'Shea unveils how digital pathology and AI are rewriting the rules of diagnostics in his latest chat with Pathology News. We're not just solving challenges; we're setting new standards. #Deciphex #DigitalPathology #AI #Innovation